Results 281 to 290 of about 22,239 (295)
Some of the next articles are maybe not open access.

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

Journal of the American Academy of Dermatology, 2018
Michael Benzaquen   +2 more
exaly  

Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes

Expert Opinion on Therapeutic Patents, 2003
Koen Augustyns   +2 more
exaly  

Dipeptidyl peptidase-4 inhibitors: Anti-diabetic drugs with potential effects on cancer

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2019
Ahmed M Kabel
exaly  

Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials

Current Medical Research and Opinion, 2011
Matteo Monami, Edoardo Mannucci
exaly  

Boronic acid inhibitors of dipeptidyl peptidase IV

1995
Roger J. Snow, William W. Bachovchin
openaire   +1 more source

Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors

Bioorganic and Medicinal Chemistry Letters, 2006
Carl S Crysler, Bruce E Tomczuk
exaly  

The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study

Diabetes Research and Clinical Practice, 2018
John-Michael Gamble   +2 more
exaly  

Dipeptidyl peptidase IV inhibitors derived from β-aminoacylpiperidines bearing a fused thiazole, oxazole, isoxazole, or pyrazole

Bioorganic and Medicinal Chemistry Letters, 2005
Wallace T Ashton   +2 more
exaly  

Home - About - Disclaimer - Privacy